Skip to main content

Headlines

Bayer: FDA Grants Priority Review To Lynkuet For New Indication
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AbbVie Announces FDA Approval Of JUVMO For Parkinson's Disease
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
CervoMed Advances Neflamapimod With New Tablet Formulation And FDA Dose Flexibility
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
XtalPi Submits FDA IND Application For KQTD-126 In Chronic Intestinal Pain
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Sanofi's Sarclisa Granted FDA Priority Review For Transplant-Ineligible Multiple Myeloma Treatment
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Biocon Biologics: FDA Approves YESAFILI As First Interchangeable Biological Product To Eylea
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
SAB Biotherapeutics Gets FDA Clearance To Advance Phase 1 Trial Of SAB-142 In Type-1 Diabetes
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Amgen: FDA Approves Imdelltra For Extensive-Stage Small Cell Lung Cancer Treatment
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
FDA approves Amgen's treatment for most deadly form of lung cancer 
posted:
by: CNBC US News
#channels:: #All, #News, #USA, #CNBCUSNews, #CNBC
FDA Approves Roche's HPV Self-Collection Solution In Cervical Cancer
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Eisai Initiates Rolling BLA To FDA For LEQEMBI For Early Alzheimer's Disease Treatment
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Cue Health Receives FDA Warning Letter Regarding Emergency Use Authorized COVID-19 Test
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
FDA Clears Qiagen's QIAstat-Dx Respiratory Syndromic Testing Panel
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Regeneron : Dupixent SBLA Accepted For FDA Priority Review For Adolescent Chronic Rhinosinusitis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks